1 |
Hinterberger A, Bea S. How do scientists model humanness? A qualitative study of human organoids in biomedical research. Soc Sci Med 2023;320:115676. [PMID: 36657211 DOI: 10.1016/j.socscimed.2023.115676] [Reference Citation Analysis]
|
2 |
Tamaki Y, Shibata Y, Hayakawa M, Kato N, Machii A, Ikeda Y, Nanizawa E, Hayashi Y, Suemizu H, Ito H, Ishikawa T. Treatment with hepatocyte transplantation in a novel mouse model of persistent liver failure. Biochemistry and Biophysics Reports 2022;32:101382. [DOI: 10.1016/j.bbrep.2022.101382] [Reference Citation Analysis]
|
3 |
Torizal FG, Utami T, Lau QY, Inamura K, Nishikawa M, Sakai Y. Dialysis based-culture medium conditioning improved the generation of human induced pluripotent stem cell derived-liver organoid in a high cell density. Sci Rep 2022;12:20774. [PMID: 36456801 DOI: 10.1038/s41598-022-25325-9] [Reference Citation Analysis]
|
4 |
Wang Q, Guo F, Jin Y, Ma Y. Applications of human organoids in the personalized treatment for digestive diseases. Signal Transduct Target Ther 2022;7:336. [PMID: 36167824 DOI: 10.1038/s41392-022-01194-6] [Reference Citation Analysis]
|
5 |
de Bruijn VMP, Wang Z, Bakker W, Zheng W, Spee B, Bouwmeester H. Hepatic bile acid synthesis and secretion: Comparison of in vitro methods. Toxicol Lett 2022;365:46-60. [PMID: 35724847 DOI: 10.1016/j.toxlet.2022.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Sukowati CHC, Tiribelli C. Adult Stem Cell Therapy as Regenerative Medicine for End-Stage Liver Disease. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/5584_2022_719] [Reference Citation Analysis]
|